Applied Therapeutics, Inc.
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
APLT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US03828A1016
- LEI:
- Country:
- United States of America
- Address:
- 545 FIFTH AVENUE, SUITE 1400, 10017 NEW YORK
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing transformative treatments for rare diseases with high unmet medical needs. The company's pipeline consists of novel drug candidates that target validated molecular pathways, with a focus on developing aldose reductase inhibitors for rare metabolic and central nervous system (CNS) disorders. Applied Therapeutics employs an approach designed to accelerate development from clinical trials to market approval by leveraging technological advances, new FDA guidance on biomarkers, and established clinical endpoints to address urgent patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Applied Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Applied Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Applied Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
